We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Back to Webinars
Proteomics
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity

Featured Speaker: Katie Mckenna, PhD, Postdoctoral Fellow Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Methodist Hospital

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Targeting non-small cell lung cancer using a cell carrier system to deliver an oncolytic & immunostimulatory adenovirus

Efficacy of oncolytic virotherapy in 3D cell culture and in vivo

Assessing T cell functionality with single-cell proteomics

Explore Related Resources

Access related webinars, eBooks, app notes & case studies.

Webinar
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity
Paper Summary
Mesenchymal Stromal Cell Delivery of Oncolytic Immunotherapy Improves CAR-T Cell Anti-tumor Activity
Blog
Mesenchymal Stromal Cell Delivery of Oncolytic Immunotherapy Increased Polyfunctionality and Efficacy of CAR-T Cells: Published in Molecular Therapy
awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Watch the Webinar
Back to the Top